PROTARA THERAPEUTIC INC (TARA) Stock Income Statement
NASDAQ:TARA - Nasdaq - US74365U1079 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 43.61M | 37.54M | 47.49M | 34.44M | 15.25M | |||
| Research and Development | 24.79M | 16.67M | 21.09M | 11.98M | 6.44M | |||
| Selling, General, and Administrative Expenses | 18.49M | 20.63M | 26.40M | 22.46M | 8.82M | |||
| Operating Income | -43.61M | -37.54M | -47.49M | -34.44M | -15.25M | |||
| Interest Income/Expense | 3.19M | 1.11M | 240.00K | 470.00K | 260.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | -29.52M | N/A | N/A | N/A | |||
| Income Before Taxes | -40.42M | -65.95M | -47.25M | -33.98M | -14.99M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -40.42M | -65.95M | -47.25M | -33.98M | -14.99M | |||
| EBITDA | -43.27M | -37.29M | -47.37M | -34.34M | -14.97M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.57 | -5.86 | -4.21 | -4.70 | -29.98 | |||
| Non GAAP EPS | -3.57 | -3.99 | -4.21 | -4.73 | -30.15 | |||
| Statistics | ||||||||
All data in USD